Production of Two Vaccinating Recombinant Rotavirus Proteins in the Milk of Transgenic Rabbits Article Received: 06 April 2005 Accepted: 05 August 2005 DOI:
Cite this article as: Soler, E., Saux, A.L., Guinut, F. et al. Transgenic Res (2005) 14: 833. doi:10.1007/s11248-005-1771-0 Abstract
Rotaviruses are the main cause of infantile viral gastroenteritis worldwide leading to approximately 500,000 deaths each year mostly in the developing world. For unknown reasons, live attenuated viruses used in classical vaccine strategies were shown to be responsible for intussusception (a bowel obstruction). New strategies allowing production of safe recombinant non-replicating rotavirus candidate vaccine are thus clearly needed. In this study we utilized transgenic rabbit milk as a source of rotavirus antigens. Individual transgenic rabbit lines were able to produce several hundreds of micrograms per ml of secreted recombinant VP2 and VP6 proteins in their milk. Viral proteins expressed in our model were immunogenic and were shown to induce a significant reduction in viral antigen shedding after challenge with virulent rotavirus in the adult mouse model. To our knowledge, this is the first report of transgenic mammal bioreactors allowing the rapid co-production of two recombinant viral proteins in milk to be used as a vaccine.
Keywords bioreactor milk rotavirus VP2 VP6 Abbreviations RV
References Attal, J, Theron, MC, Kann, G, Bolifraud, P, Puissant, C, Houdebine, LM 2000 The stimulation of gene expression by the R region from HTLV-1 and BLV J Biotechnol 2–3 179 189 Google Scholar Bertolotti-Ciarlet, A, Ciarlet, M, Crawford, SE, Conner, ME, Estes, MK 2003 Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice Vaccine 25–26 3885 3900 Google Scholar Bijvoet, AG, et al. 1999 Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II Hum Mol Genet 12 2145 2153 Google Scholar Burns, JW, Siadat-Pajouh, M, Krishnaney, AA, Greenberg, HB 1996 Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity Science 5258 104 107 Google Scholar CDC 1999 Centers for Disease Control and Prevention: withdrawal of rotavirus vaccine recommendation MMWR Morb Mortal Wkly Rep 43 1007 Google Scholar Charpilienne, A, Lepault, J, Rey, F, Cohen, J 2002 Identification of rotavirus VP6 residues located at the interface with VP2 that are essential for capsid assembly and transcriptase activity J Virol 15 7822 7831 Google Scholar Charpilienne, A, Nejmeddine, M, Berois, M, Parez, N, Neumann, E, Hewat, E, et al. 2001 Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells J Biol Chem 31 29361 29367 Google Scholar Choi, AH, Basu, M, McNeal, MM, Bean, JA, Clements, JD, Ward, RL 2004 Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice Protein Expr Purif 2 205 216 Google Scholar Choi, AH, Basu, M, McNeal, MM, Flint, J, VanCott, JL, Clements, JD, et al. 2000 Functional mapping of protective domains and epitopes in the rotavirus VP6 protein J Virol 24 11574 11580 Google Scholar Ciarlet, M, Crawford, SE, Barone, C, Bertolotti-Ciarlet, A, Ramig, RF, Estes, MK, et al. 1998 Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity J Virol 11 9233 9246 Google Scholar Coste, A, Sirard, JC, Johansen, K, Cohen, J, Kraehenbuhl, JP 2000 Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea J Virol 19 8966 8971 Google Scholar Emslie, KR, Molloy, MP, Barardi, CR, Jardine, D, Wilkins, MR, Bellamy, AR, et al. 2000 Serotype classification and characterisation of the rotavirus SA11 VP6 protein using mass spectrometry and two-dimensional gel electrophoresis Funct Integr Genom 1 12 24 Google Scholar
Estes MK (1996) Rotaviruses and their replication.
Fields Virol:1625–1650. Fan, J, Watanabe, T 2003 Transgenic rabbits as therapeutic protein bioreactors and human disease models Pharmacol Ther 3 261 282 Google Scholar Feng, N, Burns, JW, Bracy, L, Greenberg, HB 1994 Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus J Virol 12 7766 7773 Google Scholar Fromantin, C, Jamot, B, Cohen, J, Piroth, L, Pothier, P, Kohli, E 2001 Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response J Virol 22 11010 11016 Google Scholar Garcia-Diaz, A, Lopez-Andujar, P, Diaz, JR, Montava, R, Barcelo, CT, Ribes, JM, et al. 2004 Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies Vaccine 4 489 498 Google Scholar Gavel, Y, von Heijne, G 1990 Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering Protein Eng 5 433 442 Google Scholar Glass, RI, Bresee, JS, Parashar, UD, Jiang, B, Gentsch, J 2004 The future of rotavirus vaccines: a major setback leads to new opportunities Lancet 9420 1547 1550 Google Scholar Houdebine, LM 2000 Transgenic animal bioreactors Transgenic Res 4–5 305 320 Google Scholar Houdebine, LM 2002 Antibody manufacture in transgenic animals and comparisons with other systems Curr Opin Biotechnol 6 625 629 Google Scholar Houdebine, LM, Attal, J, Vilotte, JL 2002 Pinkert, Carl A. eds. Vector Design for Transgene Expression Transgenic Animal Technology, 2nd edn Academic Press New york 419 458 Google Scholar Kim, TG, Langridge, WH 2003 Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato Plant Cell Rep 9 884 890 Google Scholar Kim, TG, Langridge, WH 2004 Synthesis of an HIV-1 Tat transduction domain-rotavirus enterotoxin fusion protein in transgenic potato Plant Cell Rep 6 382 387 Google Scholar Koles, K, Berkel, PH, Mannesse, ML, Zoetemelk, R, Vliegenthart, JF, Kamerling, JP 2004 Influence of lactation parameters on the N-glycosylation of recombinant human C1 inhibitor isolated from the milk of transgenic rabbits Glycobiology 11 979 986 Google Scholar Labbe, M, Charpilienne, A, Crawford, SE, Estes, MK, Cohen, J 1991 Expression of rotavirus VP2 produces empty corelike particles J Virol 6 2946 2952 Google Scholar Lepault, J, Petitpas, I, Erk, I, Navaza, J, Bigot, D, Dona, M, et al. 2001 Structural polymorphism of the major capsid protein of rotavirus EMBO J 7 1498 1507 Google Scholar Ma, JK, Drake, PM, Christou, P 2003 The production of recombinant pharmaceutical proteins in plants Nat Rev Genet 10 794 805 Google Scholar Mathieu, M, Petitpas, I, Navaza, J, Lepault, J, Kohli, E, Pothier, P, et al. 2001 Atomic structure of the major capsid protein of rotavirus: implications for the architecture of the virion EMBO J 7 1485 1497 Google Scholar Matsumura, T, Itchoda, N, Tsunemitsu, H 2002 Production of immunogenic VP6 protein of bovine group A rotavirus in transgenic potato plants Arch Virol 6 1263 1270 Google Scholar O’Neal, CM, Crawford, SE, Estes, MK, Conner, ME 1997 Rotavirus virus-like particles administered mucosally induce protective immunity J Virol 11 8707 8717 Google Scholar Recillas-Targa, F, Pikaart, MJ, Burgess-Beusse, B, Bell, AC, Litt, MD, West, AG, et al. 2002 Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities Proc Natl Acad Sci USA 10 6883 6888 Google Scholar Rival-Gervier, S, Pantano, T, Viglietta, C, Maeder, C, Prince, S, Attal, J, Jolivet, G, Houdebine, LM 2003 The insulator effect of the 5′HS4 region from the beta-globin chicken locus on the rabbit WAP gene promoter activity in transgenic mice Transgenic Res 6 723 730 Google Scholar Rival-Gervier, S, Viglietta, C, Maeder, C, Attal, J, Houdebine, LM 2002 Position-independent and tissue-specific expression of porcine whey acidic protein gene from a bacterial artificial chromosome in transgenic mice Mol Reprod Dev 2 161 167 Google Scholar Roberts, L 2004 Vaccines Rotavirus vaccines’ second chance Science 5692 1890 1893 Google Scholar
Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual.
Schwartz-Cornil, I, Benureau, Y, Greenberg, H, Hendrickson, BA, Cohen, J 2002 Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins J Virol 16 8110 8117 Google Scholar Seeburg, PH 1982 The human growth hormone gene family: nucleotide sequences show recent divergence and predict a new polypeptide hormone DNA 3 239 249 Google Scholar
Soler E, Fourgeux C, Parez N, Garbarg-Chenon A, Schwartz-Cornil I, Cohen J et al. (2004a) Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals.
European Patent Reference ( EPO) EP 04290589.3
Soler E et al. (2004b) Preparation of recombinant rotavirus 2/6 virus-like particles in milk of transgenic mice.
International Meeting on “ Vaccination Against Enteric Diseases”. Montego Bay, Jamaica Stowers, AW, et al. 2002 A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum Proc Natl Acad Sci USA 1 339 344 Google Scholar Taboit-Dameron, F, Malassagne, B, Viglietta, C, Puissant, C, Leroux-Coyau, M, et al. 1999 Association of the 5′HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits Transgenic Res 3 223 235 Google Scholar Tosser, G, Labbe, M, Bremont, M, Cohen, J 1992 Expression of the major capsid protein VP6 of group C rotavirus and synthesis of chimeric single-shelled particles by using recombinant baculoviruses J Virol 10 5825 5831 Google Scholar Vesikari, T, Karvonen, A, Korhonen, T, Espo, M, Lebacq, E, Forster, J, et al. 2004 Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants Vaccine 21–22 2836 2842 Google Scholar Wigdorovitz, A, et al. 2004 Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants J Gen Virol Pt 7 1825 1832 Google Scholar Wu, YZ, et al. 2003 Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA Virology 2 337 342 Google Scholar Yang, K, Wang, S, Chang, KO, Lu, S, Saif, LJ, Greenberg, HB, et al. 2001 Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection Vaccine 23–24 3285 3291 Google Scholar Yu, J, Langridge, W 2003 Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice Transgenic Res 2 163 169 Google Scholar